Effect of cellular therapy in progression of Becker’s muscular dystrophy: a case study

Submitted: 17 September 2015
Accepted: 22 January 2016
Published: 31 March 2016
Abstract Views: 1592
PDF: 886
HTML: 788
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Becker muscular dystrophy (BMD) is an inherited disorder due to deletions of the dystrophin gene that leads to muscle weakness. Effects of bone marrow mononuclear cell (BMMNC) transplantation in Muscular Dystrophy have shown to be safe and beneficial. We treated a 20-year-old male suffering from BMD with autologous BMMNC transplantation followed by multidisciplinary rehabilitation. He presented with muscle weakness and had difficulty in performing his activities. The BMMNCs were transplanted via intrathecal and intramuscular routes. The effects were measured on clinical and functional changes. Over 9 months, gradual improvement was noticed in muscle strength, respiratory functions and North Star Ambulatory Assessment Scale. Functional Independence Measure, Berg Balance Score, Brooke and Vignos Scale remained stable indicating halting of the progression. The case report suggests that cellular therapy combined with rehabilitation may have possibility of repairing and regenerating muscle fibers and decreasing the rate of progression of BMD.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Sharma, A., Sane, H., Gokulchandra, N., Sharan, R., Paranjape, A., Kulkarni, P., Yadav, J., & Badhe, P. (2016). Effect of cellular therapy in progression of Becker’s muscular dystrophy: a case study. European Journal of Translational Myology, 26(1). https://doi.org/10.4081/ejtm.2016.5522